Prospective, Randomized Phase II Clinical Trial to Select Primary Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer Stage FIGO [International Federation of Gynecology and Obstetrics] IIIC and IV

Trial Profile

Prospective, Randomized Phase II Clinical Trial to Select Primary Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer Stage FIGO [International Federation of Gynecology and Obstetrics] IIIC and IV

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Carboplatin; Docetaxel
  • Indications Ovarian cancer
  • Focus Therapeutic Use
  • Acronyms PRIMOVAR1
  • Most Recent Events

    • 08 Jan 2010 Status changed from recruiting to completed.
    • 08 Jan 2010 Results reported in Oncology Reports.
    • 07 Jan 2010 Primary endpoint 'Tumour volume' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top